HOME >> BIOLOGY >> NEWS
UNC Center for Genome Sciences to inaugurate new seminar series with help of national experts

CHAPEL HILL -- The University of North Carolina at Chapel Hills new Center for Genome Sciences will kick off a seminar series on functional genomics, proteomics and bioinformatics Aug. 27 with a talk by Dr. Oliver Smithies, one of the universitys most distinguished scientists.

More than a dozen other national experts in those fields will follow during the 2001-2002 academic year. Smithies address is titled Mouse Solutions to Pharmacological Problems. He is excellence professor of pathology and laboratory medicine at the UNC School of Medicine. He also is developer of gene targeting, a renowned technique that allows scientists to disable genes in mice and breed successive generations of the animals to learn what role genes play in mammals, including humans.

Talks are free, and the public is encouraged to attend. All but the Oct. 1 presentation will be held on Mondays from noon to 1:30 p.m. in Room 136 of the Tate-Turner-Kuralt Building, located off Pittsboro Street. Genomics and proteomics are studies of information in genes and proteins, respectively, and bioinformatics is the science of handling and using biological data.

This is an exciting opportunity for the university community and the public to hear from some of the nations top scientists about the revolution in our current understanding of what genes and proteins do, said Dr. Harold L. Kohn. Kenan professor of medicinal chemistry at the school of pharmacy, Kohn co-chairs the new seminar series with Dr. Jeffrey L. Dangl, John N. Couch professor of biology.

The Human Genome Project is nearly complete, Kohn said. It has provided a wealth of sequence information leading to identification of all known genes. Similarly, rapid progress is being made to sequence the genetic material of known pathogens and organisms that affect life and well being.

The next challenge will be to provide meaning to this vast catalog of information, a challenge orders of magnitude more difficult than th
'"/>

Contact: David Williamson
David_Williamson@unc.edu
University of North Carolina at Chapel Hill
16-Aug-2001


Page: 1 2 3

Related biology news :

1. NIH awards $18.2m to The Burnham Institute to develop Center on Proteolytic Pathways
2. Joslin Diabetes Center honors brothers living 70-plus years with type 1 diabetes
3. K-States National Agricultural Biosecurity Center receives $1.3 Million from Department of Defense
4. Joslin Diabetes Center adds first affiliate in California at Irvine Medical Center
5. NHGRI launches Centers for Excellence in Ethical, Legal, and Social Implications Research
6. NIGMS funds Center for Quantitative Biology
7. Joslin Diabetes Center launches research section on developmental and stem cell biology
8. Joslin Diabetes Center releases new low impact exercise video
9. Workforce achievements celebrated at NASA Marshall Center Awards ceremony
10. National Bioinformatics Resource Center to support infectious disease research
11. National Parkinson Foundation designates UNC as Center of Excellence

Post Your Comments:
(Date:8/21/2014)... , Aug. 21, 2014 /PRNewswire-iReach/ -- ... it has agreed to a partnership with Gabriel ... fastest growing Certified Nursing Assistant ... Health Institute  an exclusive member of Binary,s LiveScan ... Binary Biometrics will improve its service capabilities ...
(Date:8/21/2014)... In a finding that has implications for life in ... in the solar system, LSU Associate Professor of Biological ... National Science Foundation, or NSF, this week published a ... lake that lies 800 meters (2600 feet) beneath the ... microbial ecosystems.", Given that more than 400 subglacial lakes ...
(Date:8/21/2014)... Oct. 18-22, 2014 , WHERE: , San ... Diego, CA 92101 , WHAT: , Invited ... the latest research in human genetics. Examples of ... abstracts on rare genetic variants in health and ... for sun sensitivity (Saturday, Oct. 18, 5:30-7:30 pm) ...
Breaking Biology News(10 mins):LiveScan Provider Binary Biometrics Announces Partnership with Preeminent CNA School, Gabriel Health Institute to Expand Services in Orlando Region 2LiveScan Provider Binary Biometrics Announces Partnership with Preeminent CNA School, Gabriel Health Institute to Expand Services in Orlando Region 3800 meters beneath Antarctic ice sheet, subglacial lake holds viable microbial ecosystems 2800 meters beneath Antarctic ice sheet, subglacial lake holds viable microbial ecosystems 3800 meters beneath Antarctic ice sheet, subglacial lake holds viable microbial ecosystems 4American Society of Human Genetics 2014 Annual Meeting 2
(Date:8/21/2014)... (PRWEB) August 21, 2014 Pursuit ... selling optimization technology and services for Life Sciences ... “Grading Pharma’s Use of New Commercial Sales Models” ... & Analytics. , The article examines some innovative ... that are being tested in the pharmaceutical market. ...
(Date:8/21/2014)... August 21, 2014 Gallus ... contract development and manufacturing organization (CMO) announced today ... Inc., an oncology company focused on the development ... to manufacture the anti-prostate specific membrane antigen (PSMA) ... candidate. Under the agreement the antibody will ...
(Date:8/21/2014)... of last week RENU 28, the world's first and only ... purchase in Australia and New Zealand, and the response has ... if you think about the definition of aging, it's really ... your body. If you think about the definition of anti-aging, ... RENU 28 does is it works with these tiny little ...
(Date:8/20/2014)... inventions licensed to biotechnology firms has revealed early ... these roadblocks, the researchers suggest that better communication ... could lead to faster commercialization down the road. ... made in university laboratories and licensed to biotechnology ... which have a high failure rate. But a ...
Breaking Biology Technology:Pursuit's Peter Robinson Publishes "Grading Pharma's Use of New Commercial Sales Models" 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 3RENU 28 Skin Care Now Available in Australia and New Zealand 2Early bottlenecks in developing biopharmaceutical products delay commercialization 2Early bottlenecks in developing biopharmaceutical products delay commercialization 3
Cached News: